重症患者肺部超声引导液体管理方案:多中心随机对照试验研究方案
这是一项前瞻性多中心随机对照试验方案,拟纳入500例ICU患者按1:1随机分为肺部超声引导的流程化液体管理组或常规治疗组。干预组每日评估B线评分,当B线评分≥15时触发使用袢利尿剂(呋塞米)清除过多液体,若利尿剂失败则采用超滤强制清除。主要终点为随机化后28天全因死亡。
要点
- 干预组每日评估B线评分,B线评分≥15时触发袢利尿剂(呋塞米)清除液体。
- 若利尿剂再平衡容量状态失败,则采用超滤强制清除液体。
- 主要终点为随机化后28天全因死亡,次要结局包括器官功能障碍、住院时长等。
核心结论
- 若研究结果显示肺部超声引导的液体管理方案改善ICU患者结局,将为其他研究完善该方案及识别最大获益患者类别奠定基础。
研究设计与样本
- 前瞻性、多中心、随机对照试验,拟纳入500例ICU患者,按1:1比例随机分配至肺部超声引导的流程化液体管理组或常规治疗组。
- 试验干预从ICU入住时开始,包括每日评估B线评分。
主要发现
- 原文为研究方案,未报告试验结果。
关键数值与推荐
- 当B线评分≥15时,触发使用袢利尿剂(呋塞米)清除过多液体。
- 若使用利尿剂再平衡容量状态失败,则采用超滤强制清除液体。
- 主要终点为随机化后28天全因死亡。
- 次要结局包括器官功能障碍的存在与时间演变、ICU住院时长和住院时长、90天全因死亡率及卫生经济学数据。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In routine intensive care unit (ICU) practice, fluids are often administered without a safety limit, which may lead to fluid overload and decreased survival. Recently, B-lines score (BLS) has been validated as a lung ultrasound (LUS) quantification of pulmonary congestion. This suggests that LUS may provide a safety threshold to conduct fluid therapy and to avoid overhydration. However, there is no randomized study to test the utility of LUS in guiding fluid management in ICU patients by using a pre-specified BLS cut-off value as a threshold for fluid removal. METHODS: LUS Guided Fluid Management Protocol for the Critically Ill Patient is a prospective, multi-centre, randomized controlled trial. Five hundred ICU patients will be randomly assigned in a 1:1 ratio, to protocolized LUS-based fluid management or usual care. The trial intervention will start on ICU admission and will consist in daily assessment of BLS and triggered evacuation of excessive fluids with loop diuretics (Furosemide) when BLS ≥ 15. If rebalancing volume status with diuretics fails, forced evacuation by ultrafiltration will be used. The main endpoint is death from all causes at 28 days from randomization. The secondary outcomes are presence and time-course evolution of organ dysfunctions, ICU- and hospital length of stay, all-cause mortality at 90 days, and health economics data. DISCUSSION: If study results will show that LUS guided fluid management protocol improves outcome in ICU patients, it will be the base for other studies to refine this protocol or track those categories of critically ill patients to whom it may bring maximum benefits. TRIAL REGISTRATION: ClinicalTrials.gov, NCT03393065 . Registered on 8 January 2018.
引用
- Rusu DM, Siriopol I, Grigoras I, et al. Lung Ultrasound Guided Fluid Management Protocol for the Critically Ill Patient: study protocol for a multi-centre randomized controlled trial. Trials. 2019. PMID: 31023358. doi:10.1186/s13063-019-3345-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。